Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
Go back to Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer| (NASDAQ: DNLI) | Delayed: 22.56 -0.29 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.85 | 52 Week High | $ | |||
| Open | $23.00 | 52 Week Low | $ | |||
| Day High | $23.03 | P/E | N/A | |||
| Day Low | $22.35 | EPS | $ | |||
| Volume | 1,088,103 | |||||

